|
CCDC93 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.424130E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.685150E-01 |
| Normal-vs-Stage2 |
1.895420E-01 |
| Normal-vs-Stage3 |
2.26660000000045E-05 |
| Normal-vs-Stage4 |
1.64293999999066E-05 |
| Stage1-vs-Stage2 |
5.717600E-01 |
| Stage1-vs-Stage3 |
7.366600E-04 |
| Stage1-vs-Stage4 |
2.032300E-04 |
| Stage2-vs-Stage3 |
1.466030E-01 |
| Stage2-vs-Stage4 |
9.307800E-02 |
| Stage3-vs-Stage4 |
7.125600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.433700E-04 |
| Normal-vs-AfricanAmerican |
3.678400E-01 |
| Normal-vs-Asian |
2.440400E-02 |
| Caucasian-vs-AfricanAmerican |
1.564630E-01 |
| Caucasian-vs-Asian |
7.062800E-03 |
| AfricanAmerican-vs-Asian |
5.605500E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.647500E-04 |
| Normal-vs-Female |
4.285600E-02 |
| Male-vs-Female |
1.621180E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.753500E-02 |
| Normal-vs-Age(41-60Yrs) |
3.089700E-02 |
| Normal-vs-Age(61-80Yrs) |
1.402850E-03 |
| Normal-vs-Age(81-100Yrs) |
3.658100E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.220600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.594400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.391000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.445400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.113600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.238400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.535800E-01 |
| Normal-vs-Grade 2 |
1.682810E-01 |
| Normal-vs-Grade 3 |
2.783400E-04 |
| Normal-vs-Grade 4 |
2.89629999983276E-07 |
| Grade 1-vs-Grade 2 |
2.847800E-01 |
| Grade 1-vs-Grade 3 |
2.573600E-02 |
| Grade 1-vs-Grade 4 |
1.319800E-03 |
| Grade 2-vs-Grade 3 |
1.593580E-02 |
| Grade 2-vs-Grade 4 |
3.64179999999825E-05 |
| Grade 3-vs-Grade 4 |
1.544200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.125000E-01 |
| Normal-vs-ccB subtype |
8.167700E-04 |
| ccA subtype-vs-ccB subtype |
9.758200E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.876700E-03 |
| Normal-vs-N1 |
2.253800E-02 |
| N0-vs-N1 |
5.058000E-01 |
|
|
